A Study of Navenibart in Participants With Hereditary Angioedema

NCT06842823 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema (HAE)

Interventions

DRUG: navenibart
DRUG: Placebo

Sponsor

Astria Therapeutics, Inc.